21-hydroxylase deficiency MRI

	Congenital adrenal hyperplasia main page
	21-hydroxylase deficiency Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 21-Hydroxylase Deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
21-hydroxylase deficiency MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of 21-hydroxylase deficiency MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on 21-hydroxylase deficiency MRI
CDC on 21-hydroxylase deficiency MRI
21-hydroxylase deficiency MRI in the news
Blogs on 21-hydroxylase deficiency MRI
Directions to Hospitals Treating 21-Hydroxylase Deficiency
Risk calculators and risk factors for 21-hydroxylase deficiency MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]

Overview

On abdominal MRI, 21-hydroxylase deficiency is characterized by bilateral symmetric enlargement of the adrenal glands.

On abdominal MRI, 21-hydroxylase deficiency is characterized by bilateral symmetric enlargement of the adrenal glands.^[1]

↑ Agrons M, Jensen CT, Habra MA, Menias CO, Shaaban AM, Wagner-Bartak NA, Roman-Colon AM, Elsayes KM (2017). "Adrenal Cortical Hyperplasia: Diagnostic Workup, Subtypes, Imaging Features and Mimics". Br J Radiol: 20170330. doi:10.1259/bjr.20170330. PMID 28707538.